Key result
ATTR patients exhibit a VE/VCO2 slope ~2.5 higher than AL, indicating greater ventilatory inefficiency.
Why the study?
Cardiopulmonary exercise testing is underexplored in cardiac amyloidosis.
What are the differences in VE/VCO2 slope and peak VO2 across cardiac amyloidosis subtypes and CPET modalities?
Meta-Analysis (n=1,505)
What are the differences in VE/VCO2 slope and peak VO2 across cardiac amyloidosis subtypes and CPET modalities?
Effect estimate: Difference 2.5 (95% CI 0.2-4.8)
Patients with ATTR cardiac amyloidosis exhibit higher VE/VCO2 slopes compared to AL patients, and peak VO2 measurements vary significantly by CPET exercise modality.
ATTR patients show greater ventilatory inefficiency than AL; leaves open whether CPET refines subtype prognosis or management.
In cardiac amyloidosis (CA) cardiopulmonary exercise testing (CPET) is underexplored. This study evaluated exercise limitations in CA using CPET, focusing on the ventilation‐to‐carbon dioxide production (VE/VCO 2 ) slope and peak oxygen uptake (VO 2 ). Seventeen studies involving 1505 patients were analyzed and systematically reviewed according to PRISMA reporting guidelines. Subgroup analyses assessed differences by diagnosis (ATTR vs. AL), CPET modality, and age. The cohort included 12% with AL, 80% with ATTR (23% hereditary [ATTRv], 70% wild‐type [ATTRwt], 7% unspecified), and 8% unidentified subtypes. VE/VCO 2 slope was elevated across ATTR subgroups: 38.4 (95% CI: 36.9–40.0, I 2 = 57%) in ATTRwt and 37.9 (95% CI: 35.1–40.7, I 2 = 70%) in ATTRv. ATTR patients were older than AL patients by 9.0 years (95% CI: 0.4–17.6, I 2 = 88%) and had a higher VE/VCO 2 slope: 2.5 (95% CI: 0.2–4.8, I 2 = 0%). CPET modality influenced peak VO 2 , which was lowest for treadmill exercise (13.7, 95% CI: 12.7–14.8, I 2 = 0%, mL/min/kg) compared to upright cycle ergometry (14.7, 95% CI: 14.3–15.1, I 2 = 33%) and semi‐recumbent cycle ergometry (14.5, 95% CI: 14.1–14.9, I 2 = 28%). A high VE/VCO 2 slope characterizes both ATTRwt and ATTRv, while AL patients are younger with lower VE/VCO 2 slope levels. Peak VO 2 in ATTR patients may depend on exercise modality.
No takes yet. Share an insight, caveat, or question.
Willixhofer et al. (2025) conducted a meta-analysis in Cardiac amyloidosis (n=1,505). ATTR diagnosis vs. AL diagnosis was evaluated on VE/VCO2 slope difference (ATTR vs AL) (Difference 2.5, 95% CI 0.2-4.8). ATTR cardiac amyloidosis patients exhibited a higher VE/VCO2 slope compared to AL patients (difference 2.5; 95% CI 0.2-4.8), indicating greater ventilatory inefficiency.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: